Collaborative study to establish the Low-molecular-mass heparin for assay--European Pharmacopoeia Biological Reference Preparation.
Thirty laboratories participated in a collaborative study to calibrate replacements for the 1st International Standard for Low Molecular Weight Heparin and the European Pharmacopoeia Low-molecular-mass heparin for assay Biological Reference Preparation. Two freeze-dried materials and one liquid preparation were included in the study. All three samples gave excellent intra- and inter-laboratory variations (majority of mean % geometric coefficient of variation < 10 %) when assayed against the 1st International Standard by both anti-Xa and anti-IIa assays. There were no major differences found between potency estimates using all methods and that obtained using European Pharmacopoeia method only. Overall, this study showed that the differences between the candidates are marginal. Based on the results of the study Sample B, 01/608 was established as the 2nd International Standard for Low Molecular Weight Heparin. Sample A, 01/592 and sample C, the liquid preparation, were established as replacements for the European Pharmacopoeia 'Low-molecular-mass heparin for assay' Biological Reference Preparation.
Gray
E
E
National Institute for Biological Standards and Control, Blanche Lane, Potters Bar, EN6 3QG United Kingdom.
Rigsby
P
P
Behr-Gross
M-E
ME
D002138:Calibration; D005060:Europe; D005612:Freeze Drying; D006495:Heparin, Low-Molecular-Weight / Q000032:analysis* / Q000737:chemistry / Q000592:standards*; D010602:Pharmacopoeias as Topic; D012015:Reference Standards
D006495:Heparin, Low-Molecular-Weight